APA

Hacker U. T., Schildhauer I., Barroso M. C., Kofler D. M., Gerner F. M., Mysliwietz J., Buening H., Hallek M. & King S. B. S. (20060413). Gene transfer preferentially selects MHC class I positive tumour cells and enhances tumour immunogenicity. : Cancer immunology, immunotherapy : CII.

Chicago

Hacker Ulrich T, Schildhauer Ines, Barroso Margarita Céspedes, Kofler David M, Gerner Franz M, Mysliwietz Josef, Buening Hildegard, Hallek Michael and King Susan B S. 20060413. Gene transfer preferentially selects MHC class I positive tumour cells and enhances tumour immunogenicity. : Cancer immunology, immunotherapy : CII.

Harvard

Hacker U. T., Schildhauer I., Barroso M. C., Kofler D. M., Gerner F. M., Mysliwietz J., Buening H., Hallek M. and King S. B. S. (20060413). Gene transfer preferentially selects MHC class I positive tumour cells and enhances tumour immunogenicity. : Cancer immunology, immunotherapy : CII.

MLA

Hacker Ulrich T, Schildhauer Ines, Barroso Margarita Céspedes, Kofler David M, Gerner Franz M, Mysliwietz Josef, Buening Hildegard, Hallek Michael and King Susan B S. Gene transfer preferentially selects MHC class I positive tumour cells and enhances tumour immunogenicity. : Cancer immunology, immunotherapy : CII. 20060413.